Profile data is unavailable for this security.
About the company
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
- Revenue in SEK (TTM)188.00m
- Net income in SEK5.32bn
- Incorporated1992
- Employees9.00
- LocationBure Equity ABNybrogatan 6STOCKHOLM 114 34SwedenSWE
- Phone+46 86140020
- Fax+46 86140038
- Websitehttps://www.bure.se/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RVRC Holding AB | 1.80bn | 302.00m | 6.00bn | 121.00 | 19.95 | 4.71 | 19.34 | 3.34 | 2.66 | 2.66 | 15.85 | 11.26 | 1.19 | 1.18 | 48.51 | 13,296,300.00 | 19.96 | -- | 24.68 | -- | 71.81 | -- | 16.82 | -- | 1.12 | -- | 0.0515 | -- | 17.21 | -- | -15.63 | -- | -- | -- |
| Bergman & Beving AB | 4.72bn | 191.00m | 7.12bn | 1.34k | 37.88 | 3.42 | 14.68 | 1.51 | 7.13 | 7.13 | 176.26 | 78.93 | 0.7998 | 1.93 | 4.96 | 3,524,627.00 | 3.40 | 3.50 | 4.62 | 4.94 | 47.85 | 43.62 | 4.26 | 4.01 | 0.9458 | 24.80 | 0.4479 | 44.49 | -0.5475 | 3.67 | -7.73 | 2.48 | -6.23 | 4.84 |
| Svolder AB | -81.60m | -110.10m | 7.13bn | 5.00 | -- | 1.23 | -- | -- | -1.34 | -1.34 | -0.7889 | 55.07 | -0.0142 | -- | -- | -16,320,000.00 | -1.91 | 10.20 | -1.92 | 10.26 | -- | 96.56 | -- | 94.54 | -- | -- | 0.00 | 15.09 | 57.64 | -- | 55.69 | -- | 0.00 | 14.87 |
| MedCap AB (publ) | 1.67bn | 203.30m | 7.98bn | 512.00 | 39.44 | 7.30 | 25.73 | 4.78 | 13.67 | 13.67 | 112.19 | 73.85 | 1.03 | 3.40 | 6.01 | 3,506,093.00 | 12.52 | 9.01 | 15.94 | 12.00 | 47.69 | 46.77 | 12.21 | 9.84 | 1.48 | 40.27 | 0.2052 | 0.00 | 42.84 | 17.49 | 46.43 | 47.82 | 2.82 | -- |
| Betsson AB | 11.11bn | 2.08bn | 14.55bn | 2.21k | 7.89 | 1.77 | 5.47 | 1.31 | 15.18 | 15.18 | 81.05 | 67.76 | 0.8289 | -- | 4.01 | 5,074,436.00 | 15.23 | 12.62 | 19.87 | 17.30 | 56.30 | 55.43 | 18.38 | 16.10 | -- | 13.30 | 0.185 | -- | 22.00 | 12.40 | 48.24 | 11.02 | 7.51 | -- |
| Bure Equity AB | 188.00m | 5.32bn | 27.06bn | 9.00 | 5.10 | 1.22 | 5.09 | 143.96 | 71.55 | 71.55 | 2.53 | 298.19 | 0.0096 | -- | 376.00 | 18,800,000.00 | 27.15 | 11.10 | 27.21 | 11.14 | 82.45 | 78.76 | 2,828.72 | 800.92 | -- | -- | 0.00009 | 8.96 | -6.91 | -13.43 | 151.34 | 21.12 | -- | 4.56 |
| Kinnevik AB | 936.00m | -7.55bn | 33.67bn | 46.00 | -- | 0.7135 | -- | 35.97 | -26.82 | -26.82 | 3.33 | 170.21 | 0.0165 | -- | -- | 20,347,830.00 | -13.33 | 13.28 | -13.86 | 13.51 | -- | -- | -806.41 | 486.46 | -- | 0.0653 | 0.069 | -- | -73.54 | -13.08 | 75.58 | -- | -- | -- |
| L E Lundbergforetagen AB (publ) | 28.58bn | 8.61bn | 81.02bn | 4.20k | 15.37 | 1.18 | 7.30 | 2.83 | 34.68 | 34.68 | 114.89 | 453.53 | 0.1314 | -- | -- | 6,799,239.00 | 4.45 | 5.61 | 6.40 | 8.03 | -- | 57.41 | 33.83 | 42.68 | 1.03 | -- | 0.1127 | 13.18 | -1.81 | 7.23 | 379.19 | 15.11 | 6.69 | 6.09 |
| Holder | Shares | % Held |
|---|---|---|
| AMF Fonder ABas of 30 Jun 2023 | 7.35m | 9.92% |
| Fj�rde AP-fondenas of 31 Dec 2023 | 5.81m | 7.84% |
| SEB Investment Management ABas of 30 Apr 2024 | 4.31m | 5.81% |
| The Vanguard Group, Inc.as of 09 May 2024 | 1.95m | 2.62% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.38m | 1.86% |
| Dimensional Fund Advisors LPas of 30 Apr 2024 | 1.23m | 1.66% |
| F�rsta AP-fondenas of 31 Dec 2023 | 1.20m | 1.62% |
| Handelsbanken Fonder ABas of 30 Apr 2024 | 804.50k | 1.09% |
| BlackRock Fund Advisorsas of 09 May 2024 | 705.05k | 0.95% |
| Nordea Investment Management ABas of 31 Jan 2024 | 598.92k | 0.81% |
